Innovators in Discovery
Elaine R. Mardis, PhD, spends a lot of her time studying molecules at the Institute for Genomic Medicine at Nationwide Children’s Hospital in Columbus, Ohio. What she sees is invisible to the naked eye, but her vision for what clinicians can do with the information they find in the genes of a cancer cell is clear.
For Michael A. Caligiuri, MD, the 2017-2018 AACR President, it is unacceptable that advances in cancer care and treatment don’t benefit everyone equally. Dr. Caligiuri made cancer health disparities one of the signature issues of his tenure as AACR President.
James P. Allison, PhD: Untangling the complexities of the immune system to pioneer cancer immunotherapy.
An internationally recognized leader in clinical and translational research on breast cancer, Dr. Garber developed one of the first cancer risk and prevention clinics where programs are now being expanded to several types of cancer.
W. Kimryn Rathmell, MD, PhD, director of the Division of Hematology and Oncology at Vanderbilt University Medical Center in Nashville, has twice been awarded grants by the American Association for Cancer Research (AACR). “The AACR does a great job of identifying high-risk, high-reward research,” Dr. Rathmell said.
Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Fellow of the AACR Academy John E. Dick, PhD, earns the 2020 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research.
Physician-scientist and Fellow of the AACR Academy William N. Hait, MD, PhD, encourages collaborations to intercept, prevent, and treat cancer. Throughout a varied career in academia and industry, Dr. Hait has kept his sights on benefiting patients.
A leader in the study of how mutations affecting tumor-suppressor genes cause cancer, Dr. Kaelin's research has had major clinical implications for several forms of cancer, particularly kidney cancer. Dr. Kaelin, Sir Peter J. Ratcliffe, MD, FRS, and Gregg L. Semenza, MD, PhD, were awarded the 2019 Nobel Prize in Physiology or Medicine.
Dr. Olufunmilayo Olopade, a physician-scientist and director of the Center for Clinical Cancer Genetics at the University of Chicago Medical Center seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Your donation to the American Association for Cancer Research helps our more than 47,000 members worldwide drive progress against cancer.
Donate Today